Clinical Trial Update: A Study of ADR-001 in Patients With Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for ADR-001 in decompensated liver cirrhosis across Phase 1 and Phase 2 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Liver Cirrhosis

Drugs mentioned

• ADR-001

Snippet

Sponsor: Rohto Pharmaceutical Co., Ltd. | Conditions: Decompensated Liver Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED